Synthetic acth analogue semax displays nootropic-like activity in humans

Alexander Kaplan, A. G. Kochetova, V.N. Nezavibathko, T.V. Rjasina

Neuroscience Research Communications · 1996 · 33 citations · 5 references

Concepts

Abstract

Nootropic properties of ACTH4-10 analogue, Semax, were demonstrated in experiments with human volunteers. The antihypoxic effect of Semax was shown by EEG analysis after short-term hyperventilation. Semax induced changes in the EEG similar to those seen after administration of typical nootropic drugs. Particularly important was the long-term (20-24 h) beneficial action of Semax on the work efficiency of operators after intranasal administration of 0.25− 1.0 mg of the peptide (about 4.0 − 16.0 μg/kg body weight).

References

5